BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32889014)

  • 1. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy.
    Schena FP; Anelli VW; Trotta J; Di Noia T; Manno C; Tripepi G; D'Arrigo G; Chesnaye NC; Russo ML; Stangou M; Papagianni A; Zoccali C; Tesar V; Coppo R;
    Kidney Int; 2021 May; 99(5):1179-1188. PubMed ID: 32889014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient classification and outcome prediction in IgA nephropathy.
    Diciolla M; Binetti G; Di Noia T; Pesce F; Schena FP; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Naso D
    Comput Biol Med; 2015 Nov; 66():278-86. PubMed ID: 26453758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
    Haaskjold YL; Lura NG; Bjørneklett R; Bostad L; Bostad LS; Knoop T
    Nephrol Dial Transplant; 2023 May; 38(5):1183-1191. PubMed ID: 35904322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.
    Pesce F; Diciolla M; Binetti G; Naso D; Ostuni VC; Di Noia T; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Di Sciascio E; Schena FP
    Nephrol Dial Transplant; 2016 Jan; 31(1):80-6. PubMed ID: 26047632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning in predicting
    Xu LL; Zhang D; Weng HY; Wang LZ; Chen RY; Chen G; Shi SF; Liu LJ; Zhong XH; Hong SD; Duan LX; Lv JC; Zhou XJ; Zhang H
    Front Immunol; 2023; 14():1224631. PubMed ID: 37600788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
    Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the International IgA Nephropathy Prediction Tool for use in children.
    Barbour SJ; Coppo R; Er L; Russo ML; Liu ZH; Ding J; Katafuchi R; Yoshikawa N; Xu H; Kagami S; Yuzawa Y; Emma F; Cambier A; Peruzzi L; Wyatt RJ; Cattran DC;
    Kidney Int; 2021 Jun; 99(6):1439-1450. PubMed ID: 33220356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
    Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z
    Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis.
    Bon G; Jullien P; Masson I; Sauron C; Dinic M; Claisse G; Pelaez A; Thibaudin D; Mohey H; Alamartine E; Mariat C; Maillard N
    Nephrol Dial Transplant; 2023 Sep; 38(10):2257-2265. PubMed ID: 37316441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
    Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A noninvasive artificial neural network model to predict IgA nephropathy risk in Chinese population.
    Hou J; Fu S; Wang X; Liu J; Xu Z
    Sci Rep; 2022 May; 12(1):8296. PubMed ID: 35585099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-hoc analysis of a tool to predict kidney failure in patients with IgA nephropathy.
    Schena FP; Anelli VW; Di Noia T; Tripepi G; Abbrescia DI; Stangou M; Papagianni A; Russo ML; D'Arrigo G; Manno C
    J Nephrol; 2023 Mar; 36(2):451-461. PubMed ID: 36269491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning-based diagnostic prediction of IgA nephropathy: model development and validation study.
    Noda R; Ichikawa D; Shibagaki Y
    Sci Rep; 2024 May; 14(1):12426. PubMed ID: 38816457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K
    Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
    Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
    Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.
    Rauen T; Wied S; Fitzner C; Eitner F; Sommerer C; Zeier M; Otte B; Panzer U; Budde K; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JFE; Hilgers RD; Floege J;
    Kidney Int; 2020 Oct; 98(4):1044-1052. PubMed ID: 32450154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.